You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Locally advanced urothelial cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma Trial (Avelumab)

Not yet recruiting
  • Urothelial Carcinoma
  • (no location specified)
Oct 26, 2022

Urothelial Carcinoma, Metastatic Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma Trial in Philadelphia (Enfortumab

Not yet recruiting
  • Urothelial Carcinoma
  • +2 more
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center - Philadelphia
Jun 27, 2023

Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

Recruiting
  • Urothelial Cancer
  • Beijing, China
    Beijing Cancer Hospital
Jan 18, 2023

HER2 and LA/mUC: A Multi-country Chart Review Cohort Study

Not yet recruiting
  • Urothelial Carcinoma
    • (no location specified)
    Jun 5, 2023

    Urothelial Carcinoma Trial in Shanghai (BL-B01D1, SI-B003)

    Not yet recruiting
    • Urothelial Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 27, 2023

    Combined Postoperative Radiotherapy With Kidney Sparing Surgery

    Recruiting
    • Locally Advanced
    • Urothelial Carcinoma Ureter
    • Radical surgery
    • Kidney sparing surgery+Postoperative radiotheray
    • Beijing, China
    • +1 more
    Nov 2, 2023

    Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation, Locally Advanced Urothelial Carcinoma, Metastatic

    Recruiting
    • Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation
    • +3 more
    • Cabozantinib S-malate
    • +3 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Aug 8, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Not yet recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +31 more
    • Diagnostic Laboratory Biomarker Analysis
    • Nivolumab
    • Houston, Texas
      M D Anderson Cancer Center
    Aug 18, 2022

    Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +41 more
    • Ipilimumab
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Oct 11, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +13 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Jun 8, 2022

    Advanced or Metastatic Urothelium Cancer Trial in Beijing (MRG002, Docetaxel Injection, Paclitaxel Injection)

    Not yet recruiting
    • Advanced or Metastatic Urothelium Cancer
    • Beijing, Beijing, China
      Cancer Hospital Chinese Academy of Medical Sciences
    Feb 22, 2023

    Advanced Urothelial Carcinoma, Locally Advanced Urothelial Carcinoma, Metastatic Urothelial Carcinoma Trial in Sacramento

    Recruiting
    • Advanced Urothelial Carcinoma
    • +3 more
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Jun 28, 2022

    Urothelial Carcinoma Trial (disitamab vedotin, pembrolizumab, gemcitabine)

    Not yet recruiting
    • Urothelial Carcinoma
    • disitamab vedotin
    • +4 more
    • (no location specified)
    Jun 9, 2023

    Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)

    Recruiting
    • Urothelial Carcinoma
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Mar 8, 2023

    Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter Urothelial Carcinoma, Locally Advanced Urethral

    Recruiting
    • Locally Advanced Renal Pelvis Urothelial Carcinoma
    • +20 more
    • Duarte, California
    • +16 more
    Aug 10, 2022

    Unresectable NSCLC (NSCLC) and Urothelial Cancer Trial in India (Durvalumab)

    Recruiting
    • Unresectable Non-small Cell Lung Cancer (NSCLC) and Urothelial Cancer
    • Bangalore, India
    • +10 more
    Aug 24, 2022

    Metastatic Urothelial Cancer Trial in China (Enfortumab vedotin)

    Active, not recruiting
    • Metastatic Urothelial Cancer
    • Enfortumab vedotin
    • Beijing, China
    • +7 more
    Aug 23, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +18 more
    • Los Angeles, California
    • +2 more
    Jun 28, 2022

    Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

    Recruiting
    • Advanced Bladder Urothelial Carcinoma
    • +23 more
    • Riverside, California
    • +8 more
    Jul 16, 2022

    Urinary Bladder Cancer Trial in München, Ulm, Würzburg (drug, radiation, procedure)

    Active, not recruiting
    • Urinary Bladder Cancer
    • München, Germany
    • +2 more
    Oct 19, 2022

    Urothelial Cancer Trial in Spain (Nivolumab, Ipilimumab)

    Recruiting
    • Urothelial Cancer
    • Huelva, Andalucia, Spain
    • +11 more
    Dec 1, 2022

    Melanoma, Urothelial Carcinoma, Renal Cell Carcinoma Trial in Auchenflower (RC198 Injection)

    Not yet recruiting
    • Melanoma
    • +5 more
    • RC198 Injection
    • Auchenflower, Queensland, Australia
      Research Site
    May 17, 2023

    Carcinoma, Transitional Cell, HER-2 Gene Amplification Trial in Beijing (Trastuzumab)

    Recruiting
    • Carcinoma, Transitional Cell
    • HER-2 Gene Amplification
    • Beijing, China
      National Cancer Center/Cancer Hospital, Chinese Academy of Medic
    Mar 31, 2022

    Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

    Recruiting
    • Locally Advanced or Metastatic Solid Tumors
    • +10 more
    • Aurora, Colorado
    • +6 more
    Jan 4, 2023

    Urothelial Carcinoma Trial in China (RC48-ADC)

    Active, not recruiting
    • Urothelial Carcinoma
    • Hefei, Anhui, China
    • +7 more
    Feb 20, 2022